1-1 of 1
Wendie D. den Brok
Close
Sort by
Journal Articles

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma

Clinical Trials & Observations
Diego Villa, Laurie H. Sehn, Kerry J. Savage, Cynthia L. Toze, Kevin Song, Wendie D. den Brok, Ciara L. Freeman, David W. Scott, Alina S. Gerrie
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3486–3494.
https://doi.org/10.1182/bloodadvances.2020002068
Published: 2020
Includes: Supplemental data